TipRanks
Advertisement
Advertisement
PepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target
PremiumRatingsPepGen: PGN-EDODM1 Multisystem Efficacy Potential Supports Buy Rating with Unchanged $20 Price Target
2M ago
PepGen Shareholders Back Directors and KPMG at 2026 Meeting
Premium
Company Announcements
PepGen Shareholders Back Directors and KPMG at 2026 Meeting
4M ago
Craig-Hallum bullish on PepGen, initiates with a Buy
Premium
The Fly
Craig-Hallum bullish on PepGen, initiates with a Buy
4M ago
PepGen reports Q1 EPS (26c), consensus (31c)
PremiumThe FlyPepGen reports Q1 EPS (26c), consensus (31c)
5M ago
PepGen sees cash runway into 2H27
Premium
The Fly
PepGen sees cash runway into 2H27
5M ago
Video: Deals in food and pharmaceuticals headline busy morning of M&A
Premium
The Fly
Video: Deals in food and pharmaceuticals headline busy morning of M&A
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―